This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Whether you’re producing medical devices within Europe or supplying to Europe from the rest of the world, as a manufacturer or supplier, you will need to adhere to the new EU MDR (European Medical Device Regulation).
Discover why EU MDR will change the medical device labeling landscape globally and how to best meet the impending challenges.
Organizations need to embrace the lessons learnt from current compliance efforts, such as UDI, and incorporate them into their labeling strategy to make bridging the gap easier in this new legislative landscape.
PRISYM ID is also exhibiting at the upcoming European Medical Device Regulation (MDR) Conference on 13th – 14th July in Washington DC.
With the EU Medical Device Regulation’s recent publication, the industry is currently analyzing gap assessment strategies to have a clear perspective of areas impacting medical device organizations. With provisions spanning all levels of device companies, the new regulation must be carefully interpreted and understood, in order to ensure a smooth transition in time and on budget.
The conference’s in-depth focus on the European Medical Device Regulation (EU MDR) will ensure a holistic approach to current changes in the European Union, providing participants with a plethora of enlightening solutions to complex regulatory transitions. High-level presentations will be delivered by European and US-based speakers to ensure the highest level of education, and interactive formats will also allow delegates to engage in hands-on activities aiming to build experience in conducting thorough regulatory gap assessments and developing a specific regulatory strategy updating plan.
For more information about PRISYM ID’s upcoming Webinar and/or to arrange a meeting during the EU MDR event, please visit www.prisymid.com or contact [email protected].
